Drug application
NEMBUTAL (PENTOBARBITAL SODIUM)
Drugs@FDA ANDA 083247 · SCIEGEN PHARMS
Key facts
| Drug name | NEMBUTAL |
|---|---|
| Active ingredients | PENTOBARBITAL SODIUM |
| Application type | ANDA |
| Application number | 083247 |
| Company | SCIEGEN PHARMS |
| Dosage forms | SUPPOSITORY, RECTAL |
| Strength | 30MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jan 25, 1982 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.